Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosimo Carriere

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Heart (British Cardiac Society)|March 11, 2022
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathyMassimo Mapelli, Simona Romani, Damiano Magrì, et al.
Biology|January 21, 2022
Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 PandemicMatteo Ziacchi, Leonardo Calò, Antonio D'Onofrio, et al.
International Journal of Cardiology|January 30, 2023
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score databaseBeatrice Pezzuto, Massimo Piepoli, Arianna Galotta, et al.
Circulation. Heart Failure|June 30, 2021
Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical PracticeLeonardo Calò, Valter Bianchi, Donatella Ferraioli, et al.
Scientific Reports|February 17, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O<sub>2</sub>-pulse in hypertrophic cardiomyopathyMassimo Mapelli, Nikita Baracchini, Nicola Campana, et al.
European Journal of Preventive Cardiology|August 12, 2025
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptationRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Journal of the American Heart Association|April 9, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic CardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Frontiers in Cardiovascular Medicine|July 18, 2024
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter studyGiulia Grilli, Elisabetta Salvioni, Federica Moscucci, et al.
ESC Heart Failure|February 5, 2018
Mineralocorticoid receptor antagonists for heart failure: a real-life observational studyNoemi Bruno, Gianfranco Sinagra, Stefania Paolillo, et al.
European Journal of Heart Failure|September 13, 2023
Heart failure patients with improved ejection fraction: Insights from the MECKI score databasePiergiuseppe Agostoni, Francesca Romana Pluchinotta, Elisabetta Salvioni, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Heart (British Cardiac Society)|March 11, 2022
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathyMassimo Mapelli, Simona Romani, Damiano Magrì, et al.
Biology|January 21, 2022
Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 PandemicMatteo Ziacchi, Leonardo Calò, Antonio D'Onofrio, et al.
International Journal of Cardiology|January 30, 2023
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score databaseBeatrice Pezzuto, Massimo Piepoli, Arianna Galotta, et al.
Circulation. Heart Failure|June 30, 2021
Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical PracticeLeonardo Calò, Valter Bianchi, Donatella Ferraioli, et al.
Scientific Reports|February 17, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O<sub>2</sub>-pulse in hypertrophic cardiomyopathyMassimo Mapelli, Nikita Baracchini, Nicola Campana, et al.
European Journal of Preventive Cardiology|August 12, 2025
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptationRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Journal of the American Heart Association|April 9, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic CardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Frontiers in Cardiovascular Medicine|July 18, 2024
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter studyGiulia Grilli, Elisabetta Salvioni, Federica Moscucci, et al.
ESC Heart Failure|February 5, 2018
Mineralocorticoid receptor antagonists for heart failure: a real-life observational studyNoemi Bruno, Gianfranco Sinagra, Stefania Paolillo, et al.
European Journal of Heart Failure|September 13, 2023
Heart failure patients with improved ejection fraction: Insights from the MECKI score databasePiergiuseppe Agostoni, Francesca Romana Pluchinotta, Elisabetta Salvioni, et al.
Pageof 4